Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 févr. 2017 08h00 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published in February 2017 Edition of Journal of Neurosurgery

CHARLOTTESVILLE, Va., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
12 déc. 2016 08h30 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Files Definitive Proxy Statement for Upcoming Special Meeting of Stockholders

CHARLOTTESVILLE, Va., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
14 nov. 2016 08h00 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results

CHARLOTTESVILLE, Va., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
08 nov. 2016 08h00 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Announces Uplisting to NASDAQ Capital Market

CHARLOTTESVILLE, Va., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
29 sept. 2016 10h05 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Establishes Scientific Advisory Board

CHARLOTTESVILLE, Va., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
19 sept. 2016 08h30 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Successfully Completes Animal Toxicity Studies in Preparation for Phase 3 Pivotal Trial of TSC in New Diagnosed Glioblastoma Patients

CHARLOTTESVILLE, Va., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
09 sept. 2016 08h30 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference

CHARLOTTESVILLE, Va., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFND), a clinical stage biotechnology company focused on the development of novel small molecule...
18 août 2016 08h30 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market

CHARLOTTESVILLE, Va., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
15 août 2016 16h15 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Second Quarter 2016 Results

CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...
15 août 2016 16h10 HE | Source: Diffusion Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors

CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule...

Page précédente

Page suivante